Manon Cox, PHD

Board of Directors

Manon is the Founder of NextWaveBio, providing scientific and strategic advice to biopharmaceutical companies around preclinical and clinical development, manufacturing and quality systems. Prior to starting NextWaveBio, Manon led the development of Flublok® at Protein Sciences Corporation, the only FDA approved recombinant influenza vaccine. Manon held a number of roles between 1998 and 2018 including President and Chief Executive Officer, before the company was acquired by Sanofi. Manon serves on numerous boards including Vaxxas, the Netherland-America Foundation and the International Society for Vaccines, as well as on various Scientific Advisory Boards including Epivax Therapeutics and Omnicyte.